These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 33604509)

  • 21. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.
    Barrasa H; Rello J; Tejada S; Martín A; Balziskueta G; Vinuesa C; Fernández-Miret B; Villagra A; Vallejo A; San Sebastián A; Cabañes S; Iribarren S; Fonseca F; Maynar J;
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):553-561. PubMed ID: 32278670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
    Cernigliaro A; Allotta AV; Scondotto S
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):315-322. PubMed ID: 33412824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic.
    Hartman HE; Sun Y; Devasia TP; Chase EC; Jairath NK; Dess RT; Jackson WC; Morris E; Li P; Hochstedler KA; Abbott MR; Kidwell KM; Walter V; Wang M; Wang X; Zaorsky NG; Schipper MJ; Spratt DE
    JAMA Oncol; 2020 Dec; 6(12):1881-1889. PubMed ID: 33119036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of aluminum salts on COVID-19 infected patients.
    Demir A; Erayman İ; Doğan O; Kekiliİ M
    Turk J Med Sci; 2020 Dec; 50(8):1771-1780. PubMed ID: 33315350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN).
    Sánchez-Álvarez JE; Pérez Fontán M; Jiménez Martín C; Blasco Pelícano M; Cabezas Reina CJ; Sevillano Prieto ÁM; Melilli E; Crespo Barrios M; Macía Heras M; Del Pino Y Pino MD
    Nefrologia (Engl Ed); 2020; 40(3):272-278. PubMed ID: 32389518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
    Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry.
    Fardman A; Zahger D; Orvin K; Oren D; Kofman N; Mohsen J; Tsafrir O; Asher E; Rubinshtein R; Jamal J; Efraim R; Halabi M; Shacham Y; Fortis LH; Cohen T; Klempfner R; Segev A; Beigel R; Matetzky S
    PLoS One; 2021; 16(6):e0253524. PubMed ID: 34143840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and results of a series of 59 patients with severe pneumonia due to COVID-19 admitted in the ICU.
    Serrano-Martínez JL; Machado-Casas JF; Redondo-Orts M; Manzano-Manzano F; Castaño-Pérez J; Pérez-Villares JM
    Med Intensiva (Engl Ed); 2020 Dec; 44(9):580-583. PubMed ID: 32653237
    [No Abstract]   [Full Text] [Related]  

  • 29. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.
    Gautret P; Hoang VT; Lagier JC; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106239. PubMed ID: 33408029
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 in Older Adults: A Series of 76 Patients Aged 85 Years and Older with COVID-19.
    Vrillon A; Hourregue C; Azuar J; Grosset L; Boutelier A; Tan S; Roger M; Mourman V; Mouly S; Sène D; François V; Dumurgier J; Paquet C;
    J Am Geriatr Soc; 2020 Dec; 68(12):2735-2743. PubMed ID: 33045106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019.
    Lin W; Xie Z; Li Y; Li L; Wen C; Cao Y; Chen X; Ou X; Hu F; Li F; Tang X; Cai W; Li L
    J Med Virol; 2021 Feb; 93(2):794-802. PubMed ID: 32672840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE).
    Castelo-Branco L; Tsourti Z; Gennatas S; Rogado J; Sekacheva M; Viñal D; Lee R; Croitoru A; Vitorino M; Khallaf S; Šušnjar S; Soewoto W; Cardeña A; Djerouni M; Rossi M; Alonso-Gordoa T; Ngelangel C; Whisenant JG; Choueiri TK; Dimopoulou G; Pradervand S; Arnold D; Harrington K; Michielin O; Dafni U; Pentheroudakis G; Peters S; Romano E
    ESMO Open; 2022 Jun; 7(3):100499. PubMed ID: 35644101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia).
    Sonmez A; Demirci I; Haymana C; Tasci I; Dagdelen S; Salman S; Ata N; Sahin I; Emral R; Cakal E; Atmaca A; Sahin M; Celik O; Demir T; Ertugrul D; Unluturk U; Caglayan M; Satman I
    J Diabetes; 2021 Jul; 13(7):585-595. PubMed ID: 33655669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.